Hjem › Aterosklerose › South Carolina
Kliniske studier for Aterosklerose i South Carolina
6 studier for Aterosklerose søker deltakere på steder i South Carolina.
Byer i South Carolina
Offisiell studietekst (engelsk)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Monroe Biomedical Research - Charleston, North Charleston
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07783802Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- M3 Wake Research - Charleston, Charleston
- Medical University of South Carolina, Charleston
- Walker Family Care, Little River
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT07157774Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Accellacare Charleston, Mt. Pleasant
RekruttererFase 3
Alder 45 til 99 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07037433Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Columbia Nephrology, Columbia
- CN Clinical Research LLC, Greenville
- Dialysis Clinic, Inc., Spartanburg
- og 1 flere
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 21. sep. 2026 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Charleston
- Research Site, Fort Mill
- Research Site, Mauldin
- og 1 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 24. aug. 2026 · NCT07000357Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
- Wm. Jennings Bryan Dorn VA Medical Center, Columbia, SC, Columbia
RekruttererFase 4
Alder 18 og eldre · Alle kjønn · Oppdatert 17. des. 2025 · NCT02915198Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.